Nuclear medicine technology firm Positrigo of Zurich, Switzerland, has secured European market clearance for its dedicated brain PET system, NeuroLF.
NeuroLFImage courtesy of Positrigo
The imaging device is designed to help diagnose and monitor brain diseases such as Alzheimer's disease, brain tumors, epilepsy, Parkinson's disease, and others. The company received U.S. Food and Drug Administration clearance for NeuroLF in July.
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.
